Latest Biotech News

Recent studies reveal advancements in cancer immunotherapy and diagnostics. Researchers engineered gut bacteria to boost colorectal cancer patient survival, while new antibody-cytokine fusion...

Pivotal developments include a new dual-mode CRISPR system enabling simultaneous gene activation and repression, expanding synthetic biology applications. Screening approaches have enhanced CRISPR...

Sanofi Ventures announced a $625 million cash infusion to expand investments across biotech and digital health startups, reinforcing its position as a major corporate venture fund amid capital...

The field of healthcare is rapidly adopting artificial intelligence for enhanced diagnostic and operational efficiency. UCLA leads a $16 million initiative to evaluate AI’s role in breast cancer...

Ionis Pharmaceuticals reported positive pivotal trial results for zilganersen in Alexander disease, an ultra-rare neurological disorder, and plans to file for FDA approval in 2026. Medicure Inc....

Innovations extend across diagnostic and therapeutic devices. Heartflow received FDA clearance for its next-generation plaque analysis algorithm demonstrating 21% improved detection over previous...

Pfizer has made a decisive move to reestablish itself in the obesity therapeutics market by acquiring Metsera for $4.9 billion upfront, with additional milestones potentially bringing the deal’s...

The FDA granted accelerated approval to Stealth BioTherapeutics’ elamipretide for Barth syndrome after a prolonged regulatory journey marked by earlier setbacks. Meanwhile, Bristol Myers announced...

Advances in CRISPR technology and AI are driving innovations in therapeutic development and diagnostics. Variational AI entered a collaboration with Merck to apply generative AI for small molecule...

Several pioneering studies reported major advances in neurosciences and neurotherapeutics. Ionis Pharmaceuticals succeeded in pivotal trials for an antisense oligonucleotide treating Alexander...

Innovations in oncology continue to accelerate with new diagnostic platforms and targeted therapies. Dana-Farber introduced MARLIN, an AI-driven methylation-based leukemia subtype classifier,...

Researchers are pioneering sustainable approaches to agriculture and environmental remediation. Studies reveal innovative methods such as using artificial plant devices powered by sunlight to...

Emerging research in immuno-oncology uncovers novel mechanisms and therapeutic strategies. A study in Cell Research demonstrated that blocking NNMT in tumor-associated fibroblasts reactivates...

Cutting-edge technological advances are transforming diagnostics and medical imaging. Heartflow secured FDA clearance for its next-generation plaque analysis algorithm, improving detection by 21%....

Financial and organizational shifts shape the biotech landscape as firms secure funds and realign leadership. Sanofi and its venture arm Sanofi Ventures boosted biotech investments with an...

Pfizer has announced its acquisition of Metsera for up to $7.3 billion, marking its reentry into the obesity therapeutics market. The deal includes upfront cash and contingent value rights tied to...

The U.S. FDA has approved Merck’s Keytruda Qlex, the first subcutaneous immune checkpoint inhibitor administered in about one minute. This new administration method offers a significant reduction...

Ionis Pharmaceuticals reported positive pivotal trial results for zilganersen, an antisense oligonucleotide targeting Alexander disease, a rare neurological disorder with no approved treatments....

The FDA has issued a complete response letter for Scholar Rock’s apitegromab SMA treatment following inspection failures and ongoing quality-control issues at a Novo Nordisk-owned contract...

Researchers used CRISPR genome editing in mice models to reveal that different EML4-ALK gene fusion variants in lung adenocarcinoma drive distinct tumor growth kinetics and responses to treatment....